CDKN2A and retinoblastoma: We uncovered an intact p53 response in WERI-Rb1 cells through overexpression of ARF protein; however, whether targeting miR-24 in retinoblastoma cells would increase ARF protein expression to optimal levels to elicit a p53 response remains to be investigated.